Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
1.003
+0.003 (0.28%)
Mar 14, 2025, 10:53 AM EDT - Market open

Inozyme Pharma Stock Forecast

INZY's stock price has decreased by -82.52% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 10 analysts with 12-month price forecasts for Inozyme Pharma stock have an average target of 16.9, with a low estimate of 11 and a high estimate of 30. The average target predicts an increase of 1,585.79% from the current stock price of 1.00.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $11 $16.9 $16 $30
Change +997.26% +1585.8% +1496.0% +2892.5%

Analyst Ratings

The average analyst rating for Inozyme Pharma stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 555555
Buy 222335
Hold 000000
Sell 000000
Strong Sell 000000
Total 7778810

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Raymond James
Raymond James
Buy
Maintains
$24$12
Buy Maintains $24$12 +1,097.01% Mar 12, 2025
Piper Sandler
Piper Sandler
Buy
Maintains
$30$23
Buy Maintains $30$23 +2,194.26% Mar 11, 2025
Needham
Needham
Strong Buy
Maintains
$23$15
Strong Buy Maintains $23$15 +1,396.26% Mar 11, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$16
Strong Buy Reiterates $16 +1,496.01% Mar 11, 2025
Piper Sandler
Piper Sandler
Buy
Maintains
$43$30
Buy Maintains $43$30 +2,892.52% Jan 13, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
10.53M
EPS This Year
-1.57
from -1.62
EPS Next Year
-1.68
from -1.57
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
------10.53M81.74M
Revenue Growth
-------676.25%
EPS
-5.11-2.40-1.78-1.37-1.62-1.57-1.68-1.00
EPS Growth
--------
Forward PE
--------
No. Analysts -----11104
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High n/a 39.1M 238.2M
Avg n/a 10.5M 81.7M
Low n/a n/a 2.9M

Revenue Growth

Revenue Growth 20252026202720282029
High - -
2,162.2%
Avg - -
676.2%
Low - -
-72.1%

EPS Forecast

EPS 20252026202720282029
High -1.06 -0.96 -0.72
Avg -1.57 -1.68 -1.00
Low -1.96 -2.19 -1.25

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.